Navigation Links
STAAR Surgical To Present At Wedbush And Canaccord Investor Conferences
Date:8/7/2014

MONROVIA, Calif., Aug. 7, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management will present at the following investor conferences:

The Wedbush 2014 Life Sciences Management Access Conference at the Le Parker Meridien Hotel in New York on Tuesday, August 12 at 10:20 a.m. PT/1:20 p.m. ET

The Canaccord Genuity 34th Annual Growth Conference at the InterContinental Hotel in Boston on Wednesday, August 13 at 10:00 a.m. PT/1:00 p.m. ET

Barry Caldwell, President and CEO, Hans Blickensdoerfer, President, Europe, Middle East, Latin America, and Steve Brown, CFO will offer a general overview of the Company's current business trends, recent financial results, and operational developments. A live webcast, including accompanying slides, will be available from the Company's website, under Investor Information. An archived replay of management's presentations will be available for 90 days following the event, also at www.staar.com.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 450,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.CONTACT:InvestorsMediaEVC Group

EVC GroupDoug Sherk

Nicole Kruse 415-652-9100

646-688-0425


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. STAAR Surgical Reports 10% Second Quarter Revenue Growth
2. STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31
3. STAAR Surgical Announces Second Quarter 2014 Results Release Date, Conference Call And Webcast
4. STAAR Surgical To Present At Piper Jaffray Healthcare Investor Conference
5. STAAR Surgical to Host Investor Breakfast and Webcast during the American Academy of Ophthalmologys Annual Meeting
6. STAAR Surgical Reports Continued Momentum During Third Quarter
7. STAAR Surgical Reports Strong Second Quarter Financial Results
8. STAAR Surgical Announces Second Quarter 2013 Results Release Date And Conference Call And Webcast
9. STAAR Surgical To Present At Upcoming Investor Conferences
10. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
11. STAAR Surgical Provides Preliminary First Quarter Revenue Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology:
(Date:7/24/2017)... PHILADELPHIA (PRWEB) , ... July 24, 2017 , ... ... Health , two organizations that already work hand-in-hand on an Innovation Collaboration program, ... transform the access, quality, experience and cost of the care members and patients ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 (the ... adipose filtration technology. The '398 and '324 patents cover methods and systems ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
(Date:7/24/2017)... ... July 24, 2017 , ... A ... focused on delivering end-to-end sleep health care at scale, indicates record-breaking adherence ... that adherence rates for positive airway pressure (PAP) therapy, the most widely utilized ...
(Date:7/24/2017)... Calif. (PRWEB) , ... July 24, 2017 , ... A ... from food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: ... instances in her life and how she has risen above. , In “Memories,” readers ...
Breaking Medicine News(10 mins):